KEGG   PATHWAY: vlg05213
Entry
vlg05213                    Pathway                                
Name
Endometrial cancer - Vulpes lagopus (Arctic fox)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
vlg05213  Endometrial cancer
vlg05213

Organism
Vulpes lagopus (Arctic fox) [GN:vlg]
Gene
121492863  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
121471236  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
121477352  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
121478805  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
121499678  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
121481416  phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
121496480  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
121494738  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
121475822  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
121488142  PDPK1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:2.7.11.1]
121475977  ILK; integrin-linked protein kinase [KO:K06272] [EC:2.7.11.1]
121488903  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
121482033  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
121482375  LOW QUALITY PROTEIN: RAC-gamma serine/threonine-protein kinase-like [KO:K04456] [EC:2.7.11.1]
121493415  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
121498045  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
121501608  BAD; bcl2-associated agonist of cell death [KO:K02158]
121497962  FOXO3; forkhead box protein O3 [KO:K09408]
121473934  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
121491936  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
121493142  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
121472124  HRAS; GTPase HRas isoform X1 [KO:K02833]
121479900  KRAS; GTPase KRas isoform X1 [KO:K07827]
121491321  NRAS; GTPase NRas [KO:K07828]
121483180  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
121489076  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
121494281  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
121484067  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
121495470  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
121475510  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
121486545  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
121483151  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
121478870  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
121500345  CDH1; cadherin-1 [KO:K05689]
121500539  cadherin-1-like [KO:K05689]
121478755  CTNNB1; catenin beta-1 [KO:K02105]
121486782  CTNNA3; catenin alpha-3 isoform X1 [KO:K05691]
121491957  CTNNA2; catenin alpha-2 isoform X1 [KO:K05691]
121494415  CTNNA1; catenin alpha-1 [KO:K05691]
121486746  AXIN1; axin-1 isoform X1 [KO:K02157]
121473774  AXIN2; axin-2 isoform X1 [KO:K04385]
121489860  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
121495587  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
121489623  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
121495797  TCF7; transcription factor 7 isoform X1 [KO:K02620]
121490511  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
121485032  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
121493895  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
121499098  MYC; myc proto-oncogene protein isoform X1 [KO:K04377]
121501724  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
121499929  TP53; cellular tumor antigen p53 [KO:K04451]
121473591  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
121486283  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
121479706  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
121495322  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
121484229  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
121497413  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
121472218  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
121489193  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
121473120  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
vlg04010  MAPK signaling pathway
vlg04012  ErbB signaling pathway
vlg04060  Cytokine-cytokine receptor interaction
vlg04110  Cell cycle
vlg04115  p53 signaling pathway
vlg04151  PI3K-Akt signaling pathway
vlg04310  Wnt signaling pathway
vlg04520  Adherens junction
KO pathway
ko05213   
LinkDB

DBGET integrated database retrieval system